Monday, December 12, 2016

UPDATE 1-Achaogen's lead antibiotic succeeds in two key studies

Dec 12 (Reuters) - Achaogen Inc's plazomicin, being

developed to fight multi-drug resistant bacterial infections,

was successful in two pivotal studies, prompting the company to

proceed with...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)